Willie A. Deese - Jun 23, 2022 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Director
Signature
/s/ James Stillman Hanson, attorney-in-fact
Stock symbol
GTHX
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/24/2022, 04:51 PM
Previous filing
May 25, 2022
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +10K +227.84% $0.00 14.4K Jun 23, 2022 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Options (Right to Buy) Award $0 +30K $0.00 30K Jun 23, 2022 Common Stock 30K $5.30 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock
F3 Represents 4,389 shares of common stock and 10,000 restricted stock units
F4 The shares underlying this option will vest in their entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director.